Your browser doesn't support javascript.
loading
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer.
Tsujino, Takuya; Takai, Tomoaki; Hinohara, Kunihiko; Gui, Fu; Tsutsumi, Takeshi; Bai, Xiao; Miao, Chenkui; Feng, Chao; Gui, Bin; Sztupinszki, Zsofia; Simoneau, Antoine; Xie, Ning; Fazli, Ladan; Dong, Xuesen; Azuma, Haruhito; Choudhury, Atish D; Mouw, Kent W; Szallasi, Zoltan; Zou, Lee; Kibel, Adam S; Jia, Li.
Afiliação
  • Tsujino T; Division of Urology, Department of Surgery, Brigham and Women's Hospital & Harvard Medical School, Boston, MA, USA.
  • Takai T; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Hinohara K; Division of Urology, Department of Surgery, Brigham and Women's Hospital & Harvard Medical School, Boston, MA, USA.
  • Gui F; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Tsutsumi T; Department of Medical Oncology, Dana-Farber Cancer Institute & Harvard Medical School, Boston, MA, USA.
  • Bai X; Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Miao C; Division of Urology, Department of Surgery, Brigham and Women's Hospital & Harvard Medical School, Boston, MA, USA.
  • Feng C; Division of Urology, Department of Surgery, Brigham and Women's Hospital & Harvard Medical School, Boston, MA, USA.
  • Gui B; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
  • Sztupinszki Z; Division of Urology, Department of Surgery, Brigham and Women's Hospital & Harvard Medical School, Boston, MA, USA.
  • Simoneau A; Division of Urology, Department of Surgery, Brigham and Women's Hospital & Harvard Medical School, Boston, MA, USA.
  • Xie N; Division of Urology, Department of Surgery, Brigham and Women's Hospital & Harvard Medical School, Boston, MA, USA.
  • Fazli L; Division of Urology, Department of Surgery, Brigham and Women's Hospital & Harvard Medical School, Boston, MA, USA.
  • Dong X; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA.
  • Azuma H; Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Choudhury AD; Department of Pathology, Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA.
  • Mouw KW; Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada.
  • Szallasi Z; Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada.
  • Zou L; Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada.
  • Kibel AS; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
  • Jia L; Department of Urology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Nat Commun ; 14(1): 252, 2023 01 17.
Article em En | MEDLINE | ID: mdl-36650183
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans / Male Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans / Male Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos